Shareholders of Staar Surgical rejected a proposal to sell the company to Alcon for about $1.6 billion, a win for activist investors who had campaigned to block the deal Staar, a maker of implantable ...

Hitting the ball longer off the tee is always fun — and it makes the game easier, too. The longer you can pound the ball with a driver, the shorter club you’ll have in your hand when approaching the ...

Reviewers’ Key Takeaways With numerous STAAR test prep resources and online practice tools available, students and educators can select from a wide range of practice tests to identify strengths and ...

Dear Fellow STAAR Surgical Shareholders: Yunqi Capital Limited (together with its affiliates, "Yunqi Capital" or "we") is an investment management firm that has been a committed investor in, and ...

DALLAS — The annual mandatory STAAR test will soon be gone under a new law Texas Gov. Greg Abbott signed Wednesday night. Public school students in third through eighth grades take the high-stakes ...

SAN ANTONIO — A shakeup is coming to how Texas students are tested. House Bill 8, signed into law by the governor on Wednesday, phases out the STAAR exam as we know it. Starting in 2027, students will ...

Lando Norris topped second practice for the Italian Grand Prix as he aims to bounce back from his Dutch disappointment at Monza. The McLaren driver set the bar with a 1:19.878s lap to beat Ferrari's ...

GREEN BAY – Micah Parsons, wearing Curly Lambeau’s No. 1, trotted onto Clark Hinkle Field for his first Green Bay Packers practice Sept. 1. Just more confirmation Packers fans were not dreaming last ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest announcement is out from Staar ...

Investing.com -- STAAR Surgical Company (NASDAQ: STAA) stock surged 44.8% following the announcement that Alcon (SIX:ALC) (NYSE: ALC) will acquire the company in a deal valued at approximately $1.5 ...

Alcon is building out its portfolio of lens implants, with a $1.5 billion deal to acquire the flagging Staar Surgical and its focus on correcting nearsightedness. Staar’s Evo and Visian implantable ...